The relevance of these findings was supported by an inverse correlation between miR-26a and E2F7 in ERα+ breast cancer64 and by the correlation between E2F7 levels, the risk of relapse, and the poor prognosis in breast cancer patients treated with tamoxifen.63 Here, E2F7 is linked to breast cancer.